Citations for
1GADD45G, PAX5
Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression.
Zhao L, Li S, Gan L, Li C, Qiu Z, Feng Y, Li J, Li L, Li C, Peng W, Xu C, Wang Z, Hui T, Ren G, Tao Q, Xiang T.
J Cell Mol Med 20(5):842-54. doi: 10.1111/jcmm.12768. Epub 2016 Feb 4. 2016
2MCOLN2, PAX5
PAX5 is the transcriptional activator of mucolipin-2 (MCOLN2) gene.
Valadez JA, Cuajungco MP.
Gene 555(2):194-202. doi: 10.1016/j.gene.2014.11.003. Epub 2014 Nov 6. 2015
3PAX5
Alternative splicing of the trout Pax5 gene and identification of novel B cell populations using Pax5 signatures.
Macmurray E, Barr M, Bruce A, Epp L, Zwollo P.
Dev Comp Immunol 41(2):270-81. doi: 10.1016/j.dci.2013.06.008. Epub 2013 Jun 21. 2013
4PAX5, SOX11
SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.
Vegliante MC, Palomero J, Pérez-Galán P, Roué G, Castellano G, Navarro A, Clot G, Moros A, Suárez-Cisneros H, Beŕ S, Hernández L, Enjuanes A, Jares P, Villamor N, Colomer D, Martín-Subero JI, Campo E, Amador V.
Blood 121(12):2175-85. doi: 10.1182/blood-2012-06-438937. Epub 2013 Jan 15. 2013
5AICDA, PAX5
Activation of Aicda gene transcription by Pax5 in plasmacytoma cells.
Dege C, Hagman J.
Immunol Res 55(1-3):155-61. doi: 10.1007/s12026-012-8357-8. 2013
6EBF1, PAX5
Transcription factor EBF1 is essential for the maintenance of B cell identity and prevention of alternative fates in committed cells.
Nechanitzky R, Akbas D, Scherer S, Györy I, Hoyler T, Ramamoorthy S, Diefenbach A, Grosschedl R.
Nat Immunol 14(8):867-75. doi: 10.1038/ni.2641. Epub 2013 Jun 30. 2013
7PAX5
Germline PAX5 mutations and B cell leukemia.
Hyde RK, Liu PP.
Nat Genet 45(10):1104-5. doi: 10.1038/ng.2778. 2013
8PAX5
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia.
Shah S, Schrader KA, Waanders E, Timms AE, Vijai J, Miething C, Wechsler J, Yang J, Hayes J, Klein RJ, Zhang J, Wei L, Wu G, Rusch M, Nagahawatte P, Ma J, Chen SC, Song G, Cheng J, Meyers P, Bhojwani D, Jhanwar S, Maslak P, Fleisher M, Littman J, Offit L, Rau-Murthy R, Fleischut MH, Corines M, Murali R, Gao X, Manschreck C, Kitzing T, Murty VV, Raimondi SC, Kuiper RP, Simons A, Schiffman JD, Onel K, Plon SE, Wheeler DA, Ritter D, Ziegler DS, Tucker K, Sutton R, Chenevix-Trench G, Li J, Huntsman DG, Hansford S, Senz J, Walsh T, Lee M, Hahn CN, Roberts KG, King MC, Lo SM, Levine RL, Viale A, Socci ND, Nathanson KL, Scott HS, Daly M, Lipkin SM, Lowe SW, Downing JR, Altshuler D, Sandlund JT, Horwitz MS, Mullighan CG, Offit K.
Nat Genet 45(10):1226-31. doi: 10.1038/ng.2754. Epub 2013 Sep 8. 2013
9PAX5
The transcription factor paired box-5 promotes osteoblastogenesis through direct induction of Osterix and Osteocalcin.
Hinoi E, Nakatani E, Yamamoto T, Iezaki T, Takahata Y, Fujita H, Ishiura R, Takamori M, Yoneda Y.
J Bone Miner Res 27(12):2526-34. doi: 10.1002/jbmr.1708. 2012
10PAX5
The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis.
Revilla-I-Domingo R, Bilic I, Vilagos B, Tagoh H, Ebert A, Tamir IM, Smeenk L, Trupke J, Sommer A, Jaritz M, Busslinger M.
EMBO J 31(14):3130-46. doi: 10.1038/emboj.2012.155. 2012
11AUTS2, PAX5
PAX5-AUTS2: a recurrent fusion gene in childhood B-cell precursor acute lymphoblastic leukemia.
Denk D, Nebral K, Bradtke J, Pass G, Möricke A, Attarbaschi A, Strehl S.
Leuk Res 36(8):e178-81. doi: 10.1016/j.leukres.2012.04.015. Epub 2012 May 12. Review. 2012
12PAX5
PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML.
Kurahashi S, Hayakawa F, Miyata Y, Yasuda T, Minami Y, Tsuzuki S, Abe A, Naoe T.
Oncogene 30(15):1822-30. Epub 2011 Jan 10. 2011
13FOXP1, PAX5
FOXP1 and PAX5 are rare but recurrent translocations partners in acute lymphoblastic leukemia.
Put N, Deeren D, Michaux L, Vandenberghe P.
Cancer Genet 204(8):462-4. 2011
14PAX5
The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease.
O'Brien P, Morin P Jr, Ouellette RJ, Robichaud GA.
Cancer Res 71(24):7345-50. doi: 10.1158/0008-5472.CAN-11-1874. Epub 2011 Nov 29. Review. 2011
15PAX5
The transcription factor Pax5 regulates its target genes by recruiting chromatin-modifying proteins in committed B cells.
McManus S, Ebert A, Salvagiotto G, Medvedovic J, Sun Q, Tamir I, Jaritz M, Tagoh H, Busslinger M.
EMBO J 30(12):2388-404. doi: 10.1038/emboj.2011.140. 2011
16EP300, PAX5
Histone acetyltransferase p300 acetylates Pax5 and strongly enhances Pax5-mediated transcriptional activity.
He T, Hong SY, Huang L, Xue W, Yu Z, Kwon H, Kirk M, Ding SJ, Su K, Zhang Z.
J Biol Chem 286(16):14137-45. doi: 10.1074/jbc.M110.176289. Epub 2011 Feb 25. 2011
17PAAXIP1, PAX5
Role of PTIP in class switch recombination and long-range chromatin interactions at the immunoglobulin heavy chain locus.
Schwab KR, Patel SR, Dressler GR.
Mol Cell Biol 31(7):1503-11. doi: 10.1128/MCB.00990-10. Epub 2011 Jan 31. 2011
18CD19, PAX5
Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5.
Walter K, Cockerill PN, Barlow R, Clarke D, Hoogenkamp M, Follows GA, Richards SJ, Cullen MJ, Bonifer C, Tagoh H.
Oncogene 29(20):2927-37. Epub 2010 Mar 8.PMID: 20208555 2010
19PAX5
Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia.
Nebral K, Denk D, Attarbaschi A, König M, Mann G, Haas OA, Strehl S.
Leukemia 23(1):134-43. Epub 2008 Nov 20. 2009
20ASXL1, PAX5
Heterogeneous breakpoints in patients with acute lymphoblastic leukemia and the dic(9;20)(p11-13;q11) show recurrent involvement of genes at 20q11.21.
An Q, Wright SL, Moorman AV, Parker H, Griffiths M, Ross FM, Davies T, Harrison CJ, Strefford JC.
Haematologica 94(8):1164-9. Epub 2009 Jul 7.PMID: 19586940 2009
21PAX5
PAX-5 is invariably expressed in B-cell lymphomas without plasma cell differentiation.
Dong HY, Browne P, Liu Z, Gangi M.
Histopathology 53(3):278-87. Epub 2008 Jul 16. 2008
22ATP9A, PAX5
Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer.
An Q, Wright SL, Konn ZJ, Matheson E, Minto L, Moorman AV, Parker H, Griffiths M, Ross FM, Davies T, Hall AG, Harrison CJ, Irving JA, Strefford JC.
Proc Natl Acad Sci U S A 105(44):17050-4. doi: 10.1073/pnas.0803494105. Epub 2008 Oct 28. 2008
23EBF1,IKZF1,IKZF3,LEF1,PAX5,TCF3
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.
Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds SB, Su X, Pui CH, Relling MV, Evans WE, Shurtleff SA, Downing JR.
Nature 446(7137):758-64. 2007
24MYC, PAX5, ZBTB5, ZCCHC7
Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
Bertrand P, Bastard C, Maingonnat C, Jardin F, Maisonneuve C, Courel MN, Ruminy P, Picquenot JM, Tilly H.
Leukemia 21(3):515-23. Epub 2007 Jan 18. 2007
25ELN, PAX5
A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5.
Bousquet M, Broccardo C, Quelen C, Meggetto F, Kuhlein E, Delsol G, Dastugue N, Brousset P.
Blood 109(8):3417-23. Epub 2006 Dec 19. 2007
26ETV6, FOXP1, PAX5, PML, ZNF521
Identification of PML as novel PAX5 fusion partner in childhood acute lymphoblastic leukaemia.
Nebral K, König M, Harder L, Siebert R, Haas OA, Strehl S.
Br J Haematol 139(2):269-74. 2007
27PAX5, IGH
PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements.
Poppe B, De Paepe P, Michaux L, Dastugue N, Bastard C, Herens C, Moreau E, Cavazzini F, Yigit N, Van Limbergen H, De Paepe A, Praet M, De Wolf-Peeters C, Wlodarska I, Speleman F.
Genes Chromosomes Cancer 44(2):218-23. 2005
28PAX5, ETV6
PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13).
Strehl S, Konig M, Dworzak MN, Kalwak K, Haas OA.
Leukemia 17(6):1121-3. 2003
29PAX5
Reversion of B cell commitment upon loss of Pax5 expression.
Mikkola I, Heavey B, Horcher M, Busslinger M.
Science 297(5578):110-3. 2002
30DAXX, PAX5
The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells.
Emelyanov AV, Kovac CR, Sepulveda MA, Birshtein BK.
J Biol Chem 277(13):11156-64. 2002
31CCND1, PAX5, TAL1
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry.
Falini B, Mason DY.
Blood 99(2):409-26. Review. 2002
32CCIN, CLTA, CREB3, GNE, IBM2, MELK, PAX5, RECK
Physical and transcriptional map of the hereditary inclusion body myopathy locus on chromosome 9p12-p13.
Eisenberg I, Hochner H, Shemesh M, Levi T, Potikha T, Sadeh M, Argov Z, Jackson CL, Mitrani-Rosenbaum S.
Eur J Hum Genet 9(7):501-9. 2001
33PAX5
The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case.
Cazzaniga G, Daniotti M, Tosi S, Giudici G, Aloisi A, Pogliani E, Kearney L, Biondi A.
Cancer Res 61(12):4666-70. 2001
34KPNA2, PAX5
BSAP (Pax5)-importin alpha 1 (Rch1) interaction identifies a nuclear localization sequence.
Kovac CR, Emelyanov A, Singh M, Ashouian N, Birshtein BK.
J Biol Chem 275(22):16752-7. 2000
35PAX5
Independent regulation of the two Pax5 alleles during B-cell development.
Nutt SL, et al.
Nat Genet 21(4):390-5. 1999
36PAX5
Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32).
Iida S, et al.
Leuk Lymphoma 34(1-2):25-33. Review. 1999
37PAX5
Monoallelic expression of Pax5: a paradigm for the haploinsufficiency of mammalian Pax genes?
Nutt SL, et al.
Biol Chem 380(6):601-11. Review 1999
38ETS1, PAX2, PAX3, PAX5
The highly conserved beta-hairpin of the paired DNA-binding domain is required for assembly of Pax-Ets ternary complexes.
Wheat W, Fitzsimmons D, Lennox H, Krautkramer SR, Gentile LN, McIntosh LP, Hagman J.
Mol Cell Biol 19(3):2231-41. 1999
39CD19, PAX5
Identification of BSAP (pax-5) target genes in early B-cell development by loss-and gain-of-function experiments.
Nutt SL, et al.
EMBO J 17 : 2319-2333. 1998
40PAX5
Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma.
Morrison AM, Jager U, Chott A, Schebesta M, Haas OA, Busslinger M.
Blood 92 : 3865-3878. 1998
41PAX5, KIS1
Deregulation of PAX-5 by translocation of the E mu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.
Busslinger M, et al.
Proc Natl Acad Sci U S A 93 : 6129-6134. 1996
42KIS1, PAX5
The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.
Iida S, et al.
Blood 88 : 4110-4117. 1996
43PAX5
The PAX5 gene : a linkage and mutation analysis in candidate human primary immunodeficiencies.
Vorechovsky I, et al.
Immunogenetics 42 : 149-152. 1995
44PAX5
An intragenic Taql RFLP at the PAX5 locus.
Vorechovsky I, et al.
Hum Mol Genet 3 : 681. 1994
45PAX5
SSCP/Sacl polymorphism in the PAX5 gene.
Vorechovsky I, et al.
Hum Mol Genet 3 : 839. 1994
46PAX2, PAX4, PAX5, PAX7, PAX8, PAX9
Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9.
Stapleton P, et al.
Nat Genet 3 : 292-298. 1993
47PAX5
Mapping of the human homologs of the murine paired-box-containing genes.
Pilz AJ, Povey S, Gruss P, Abbott CM.
Mamm Genome 4(2):78-82. 1993
48PAX5
Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis.
Adams B, et al.
Genes Dev 6 : 1589-1607. 1992
49PAX5
A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation.
Barberis A, et al.
Genes Dev 4 : 849-859. 1990
50PAX5, KIS1
Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen.
Ohno H, et al.
Proc Natl Acad Sci U S A 87 : 628-632. 1990